|
ITFG1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.28429999999036E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.94240000000101E-05 |
| Normal-vs-Stage2 |
2.423900E-02 |
| Normal-vs-Stage3 |
1.46519999999484E-06 |
| Normal-vs-Stage4 |
3.60090000000035E-05 |
| Stage1-vs-Stage2 |
3.518400E-01 |
| Stage1-vs-Stage3 |
7.085700E-02 |
| Stage1-vs-Stage4 |
1.106010E-01 |
| Stage2-vs-Stage3 |
5.466400E-02 |
| Stage2-vs-Stage4 |
7.459600E-02 |
| Stage3-vs-Stage4 |
8.477800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.87320000000213E-06 |
| Normal-vs-AfricanAmerican |
3.190800E-01 |
| Normal-vs-Asian |
1.968110E-04 |
| Caucasian-vs-AfricanAmerican |
3.659700E-02 |
| Caucasian-vs-Asian |
9.220800E-01 |
| AfricanAmerican-vs-Asian |
6.599900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.18870000001647E-06 |
| Normal-vs-Female |
4.09080000000062E-05 |
| Male-vs-Female |
1.871200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.36239999999999E-05 |
| Normal-vs-Age(41-60Yrs) |
1.166700E-04 |
| Normal-vs-Age(61-80Yrs) |
6.30509999999251E-05 |
| Normal-vs-Age(81-100Yrs) |
1.074380E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.634000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.810600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.958400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.294200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.619800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.817600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.364600E-03 |
| Classical-VS-Follicular |
4.395000E-01 |
| Classical-VS-Other |
4.385400E-01 |
| Classical-VS-Normal |
1.239820E-04 |
| Tall-VS-Follicular |
7.177800E-02 |
| Tall-VS-Other |
7.800400E-01 |
| Tall-VS-Normal |
2.50629999976049E-07 |
| Follicular-VS-Other |
6.487200E-01 |
| Follicular-VS-Normal |
3.202700E-04 |
| Other-VS-Normal |
2.508400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.10710000000591E-05 |
| Normal-vs-N1 |
7.10140000026449E-07 |
| N0-vs-N1 |
2.662400E-02 |
|
|
